Regencell Bioscience Holdings Ltd (RGC) — Financial Flexibility Index
Regencell Bioscience Holdings Ltd (RGC) has a Financial Flexibility Index of -9.10x as of June 2024. Free cash flow of $-2.00 Million (operating CF $-2.00 Million minus capex $2.69K) represents -9% of total liabilities ($219.51K). Check RGC PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regencell Bioscience Holdings Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Regencell Bioscience Holdings Ltd across 23 annual periods. See how liquid is Regencell Bioscience Holdings Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Regencell Bioscience Holdings Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Regencell Bioscience Holdings Ltd. For the full company profile including market capitalisation, see Regencell Bioscience Holdings Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.31x | $-2.96 Million | $-3.11 Million | $895.31K | ▲ +81.8% |
| 2024 | -18.21x | $-4.00 Million | $-4.00 Million | $219.51K | ▼ -133.2% |
| 2023 | -7.81x | $-4.94 Million | $-4.96 Million | $632.32K | ▼ -63.2% |
| 2022 | -4.78x | $-4.49 Million | $-5.27 Million | $938.03K | ▼ -153034.6% |
| 2021 | 0.00x | $13.56K | $-767.31K | $4.34 Million | ▲ +101.6% |
| 2020 | -0.19x | $-608.74K | $-726.57K | $3.16 Million | ▼ -46.6% |
| 2019 | -0.13x | $-273.15K | $-390.99K | $2.08 Million | ▼ -173.5% |
| 2018 | 0.18x | $660.30 Million | $409.90 Million | $3.70 Billion | ▼ -0.5% |
| 2017 | 0.18x | $625.40 Million | $410.50 Million | $3.48 Billion | ▲ +1.6% |
| 2016 | 0.18x | $620.10 Million | $434.40 Million | $3.51 Billion | ▲ +19.9% |
| 2015 | 0.15x | $505.90 Million | $349.10 Million | $3.43 Billion | ▲ +9.7% |
| 2014 | 0.13x | $459.00 Million | $346.90 Million | $3.42 Billion | ▼ -10.4% |
| 2013 | 0.15x | $435.80 Million | $346.60 Million | $2.91 Billion | ▼ -0.8% |
| 2012 | 0.15x | $440.30 Million | $353.10 Million | $2.91 Billion | ▲ +26.0% |
| 2011 | 0.12x | $357.80 Million | $259.40 Million | $2.98 Billion | ▼ -33.4% |
| 2010 | 0.18x | $519.60 Million | $410.80 Million | $2.88 Billion | ▲ +89.5% |
| 2009 | 0.10x | $270.00 Million | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $373.00 Million | $1.04 Billion | — |